We measured TFF2 levels in serum samples from healthy controls, as well as patients with PC and periampullary adenocarcinoma and found that TFF2 was specifically overexpressed in PC patients, but not in periampullary adenocarcinoma patients or healthy controls. This evidence concerns the gene TFF2 and periampullary adenocarcinoma.